A--Chemical Screening and Optimization Facility
A--Chemical Screening and Optimization Facility
Contact and place of performance
ST JOHN, ADELOLA O
Not specified
The objective of this contract is for a Chemical Screening and Optimization Facility (CSOF) with the capability to carry out the production of active recombinant protein, assay development, chemical screening, identification and optimization of chemical lead series and production of milligram to kilogram quantities of materials for in vitro and in vivo testing for contraception and/or reproductive health-related therapeutic indications.
The objective of solicitation 75N94023R00008 is to establish a Chemical Screening and Optimization Facility (CSOF) with the capacity to support research for contraception and reproductive health-related therapeutic indications. The facility will be responsible for the production of active recombinant protein, assay development, and chemical screening. The scope of work includes the identification and optimization of chemical lead series as well as the production of milligram to kilogram quantities of materials for in vitro and in vivo testing.
This federal opportunity is classified under NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 Health R&D Services; Health Care Services; Basic Research. The primary point of contact for this requirement is Adelola O. St. John. Documentation for the solicitation consists of two attachments including the request for proposals and a solicitation PDF, both of which were issued on April 21, 2023.
The deadline to submit responses is June 8, 2023. The notice was originally published on March 31, 2023, and received its most recent update on May 31, 2023. All activities are directed toward the synthesis and testing of materials necessary for reproductive health research.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.